Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
Résultats de la recherche
Tout
Rechercher les filtres
-
Dublin, March 21, 2025 (GLOBE NEWSWIRE) -- The "Microbiome Disease - Pipeline Insight, 2025" drug pipeline report has been added to ResearchAndMarkets.com's offering.The report provides...
-
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS) EBX-102-02 demonstrated clinically meaningful...
-
Dublin, March 06, 2025 (GLOBE NEWSWIRE) -- The "Microbiome Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
-
VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver-based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
-
Biongevity launches UAE’s top longevity plans after a record-breaking fitness challenge, integrating AI, genomics, and precision medicine for Healthspan.
-
US & Canada, Feb. 06, 2025 (GLOBE NEWSWIRE) -- According to a comprehensive report from The Insight Partners, “Human Microbiome Market Size and Forecast (2021 - 2031), Global and Regional Share,...
-
BioAro launches PanOmiQ, the world's fastest AI-driven WGS platform, delivering real-time genomic insights in under 2 hours for precision medicine.
-
Persephone Biosciences Announces Full Enrollment in AMBROSIA Food as Medicine Study
-
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic
-
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Thematic Intelligence: Microbiome-Based Therapeutics" report has been added to ResearchAndMarkets.com's offering. The analyst assesses the current...